Logo

Almirall to Accelerate Drug Discovery Process Utilizing Iktos' AI Technology

Share this

Almirall to Accelerate Drug Discovery Process Utilizing Iktos' AI Technology

Shots:

  • Almirall will leverage Iktos’s generative modeling AI technology for compound optimization and accelerating the identification of drug candidates for its drug discovery program
  • The collaboration will provide an opportunity to Almirall to combine its expertise with Iktos’ AI precision and celerity to improve QoL
  • Iktos’ AI technology is based on deep generative models helps to bring speed & efficiency to the drug discovery process by designing virtual novel molecule having characteristics of novel drug candidates

Click here to­ read full press release/ article | Ref: Businesswire | Image: Iktos


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions